New Evidence of Oral Branched-Chain Amino Acid Supplementation on the Prognosis of Patients With Advanced Liver Disease

Oral branched-chain amino acids (BCAAs) might benefit patients with advanced liver disease. We assess its effects on prognosis compared with control from the meta-analysis. METHODS: Study end points were development of hepatic encephalopathy (HE), hepatocellular carcinoma (HCC), mortality, and overa...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hankil, Yoo, Jeong-Ju, Ahn, Sang Hoon, Kim, Beom Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780118/
https://www.ncbi.nlm.nih.gov/pubmed/36250703
http://dx.doi.org/10.14309/ctg.0000000000000542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780118/
https://www.ncbi.nlm.nih.gov/pubmed/36250703
http://dx.doi.org/10.14309/ctg.0000000000000542

Ejemplares similares